MIHMex: Glass Ionomer Cement Sealant in the Prevention of Post-eruptive Fractures in Molars Affected by MIH

Sponsor
Isabel Cristina Olegário da Costa (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03870958
Collaborator
University of Guadalajara (Other), University of Dublin, Trinity College (Other), Academic Centre for Dentistry in Amsterdam (Other)
195
1
2
37
5.3

Study Details

Study Description

Brief Summary

This trial will compare the application of Glass Ionomer Cement (GIC) sealant with no-intervention for the most clinically- and cost-effective strategy for managing MIH molars without post-eruptive breakdown, in a school setting, using low-technology and child-friendly dental techniques. Methods/Design: This two-arm, parallel group, patient-randomized controlled, superiority trial will have treatment provided in schools. Schoolchildren (age 6-9), presenting at least one MIH molar (n molars = 195,) will have random allocation to treatment with or without the application of a GIC sealant (GC Fuji TRIAGE®, GC Europe, Leuven, Belgium). Baseline measures and outcome data will be assessed through participant report and clinical examination. The primary outcome is the presence of post-eruptive fracture and development of caries lesions. Secondary outcomes are: (1) self-reported dental hypersensitivity; (2) oral health-related-quality of life, reported by children; (3) plaque index, (4) gingival health, (5) caries status (according to ICCMS scores) in primary and permanent teeth; (6) the incremental cost-effectiveness. A trained and calibrated examiner will evaluate the treated teeth every six months post treatment for a period of 36 months. Kaplan-Meier and Cox regression tests will be used to investigate the primary outcome. The Logistic Regression and Poisson Regression Analysis will be used to analyze the secondary outcomes (α=5%).

Condition or Disease Intervention/Treatment Phase
  • Procedure: GIC sealant (GC Fuji TRIAGE®)
  • Procedure: Control
N/A

Detailed Description

Background: Molar-Incisor Hypomineralisation (MIH) is defined as a qualitative defect that occurs during the mineralization phase of enamel of at least one first permanent molar. The opacities vary in size and color and are demarcated by healthy enamel. MIH molars present lower mechanical properties when compared to non-affected molars, due to the enamel's decreased mineralization. Allied to that, patients often report dental hypersensitivity, which impairs the mechanical removal of dental plaque; therefore, those molars are more prone to post-eruptive fractures and present higher risk of developing dental caries. This trial will compare the application of Glass Ionomer Cement (GIC) sealant with no-intervention for the most clinically- and cost-effective strategy for managing MIH molars without post-eruptive breakdown, in a school setting, using low-technology and child-friendly dental techniques. Methods/Design: This two-arm, parallel group, patient-randomized controlled, superiority trial will have treatment provided in schools. Schoolchildren (age 6-9), presenting at least one MIH molar (n molars = 195,) will have random allocation to treatment with or without the application of a GIC sealant (GC Fuji TRIAGE®, GC Europe, Leuven, Belgium). Baseline measures and outcome data will be assessed through participant report and clinical examination. The primary outcome is the presence of post-eruptive fracture and development of caries lesions. Secondary outcomes are: (1) self-reported dental hypersensitivity; (2) oral health-related-quality of life, reported by children; (3) plaque index, (4) gingival health, (5) caries status (according to ICCMS scores) in primary and permanent teeth; (6) the incremental cost-effectiveness. A trained and calibrated examiner will evaluate the treated teeth every six months post treatment for a period of 36 months. Kaplan-Meier and Cox regression tests will be used to investigate the primary outcome. The Logistic Regression and Poisson Regression Analysis will be used to analyze the secondary outcomes (α=5%).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
195 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This two-arm, parallel group, patient-randomized controlled, superiority trial will have treatment provided in schools. Schoolchildren (age 6-9), presenting at least one MIH molar (n molars = 195,) will have random allocation to treatment with or without the application of a GIC sealant (GC Fuji TRIAGE®, GC Europe, Leuven, Belgium).This two-arm, parallel group, patient-randomized controlled, superiority trial will have treatment provided in schools. Schoolchildren (age 6-9), presenting at least one MIH molar (n molars = 195,) will have random allocation to treatment with or without the application of a GIC sealant (GC Fuji TRIAGE®, GC Europe, Leuven, Belgium).
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Cost-effectiveness of the Application of Glass Ionomer Cement Sealant (GC Fuji TRIAGE®) in the Prevention of Post-eruptive Fractures in Molars Affected by Molar-Incisor Hipomineralisation: Controlled and Randomized Clinical Trial
Actual Study Start Date :
Nov 20, 2018
Actual Primary Completion Date :
Dec 20, 2019
Anticipated Study Completion Date :
Dec 20, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: GIC sealant (GC Fuji TRIAGE®)

Children allocated to this group will receive the same dietary advices and brushing instructions. Additionally, all MIH molars from will receive a GIC sealant (GC Fuji TRIAGE®, GC Europe, Leuven, Belgium).

Procedure: GIC sealant (GC Fuji TRIAGE®)
Children allocated to this group will receive the same dietary advices and brushing instructions. Additionally, all MIH molars from will receive a GIC sealant (GC Fuji TRIAGE®, GC Europe, Leuven, Belgium).

Active Comparator: Control

Children allocated to this group will receive the same dietary advices and brushing instructions described in the control arm.

Procedure: Control
Children allocated to this group will receive the same dietary advices and brushing instructions.

Outcome Measures

Primary Outcome Measures

  1. Post-eruptive breakdown [After 12 months]

    A "success" will be accounted in cases when the no post-eruptive breakdown is detected, while a "failure" will be considered when a post-eruptive breakdown, atypical restoration, atypical caries or tooth missing due to MIH is perceived. Method: clinical evaluation by a calibrated examiner

Secondary Outcome Measures

  1. Caries lesions assessment [Every 6 months up to 36 months]

    The dental caries index ICCMS (Ismail et al., 2015) will be used. For that, a visual-tactile exam will be performed with the aid of an OMS probe. Method: clinical evaluation by a calibrated examiner

  2. Sealant retention [Every 12 months up to 36 months]

    The sealants 'retention will be clinically evaluated and scored as: 0- fully retained sealant; 1- partially retained sealant and 2- sealant absent (Oba et al., 2009). (Hilgert LA et al., 2017) Method: clinical evaluation by a calibrated examiner

  3. Oral health-related quality of life (OHRQoL) [Baseline and every 12 months up to 36 months]

    All children will be interviewed concerning their OHQoL by a local dentist. For that, the Child Perceptions Questionnaire (CPQ) will be used. This questionnaire has already been adapted and validated into Spanish-language (Carmen Aguilar-Díaz F et al., 2011).

  4. Cost-efficacy of treatments [Baseline, after treatment and every 12 months up to 36 months]

    The cost-effectiveness analysis will take into account the direct and indirect costs of the procedures. The time spent in each session will be considered, with the total time spent timed by an external assistant. The numbers of consultations attended to each participant and the procedures performed will be registered.

  5. Hypersensitivity [hypersensitivity will be evaluated at 6-month intervals so that evaluations will be completed in 6, 12, 18, 24, 30 and 36 months by the same examiner.]

    A questionnaire will be used which will be applied to children with specific questions, a) presence of hypersensitivity when ingesting hot and cold drinks; b) hypersensitivity when brushing teeth. Clinically it will be used the methodology used by Mehta D, et al., 2015. A cold air stimulus (2-s air blast, approximately 40 psi, from a dental syringe directed perpendicular to the molar surface at 0.5 cm distance). Neighboring teeth were shielded with cotton rolls or with the fingers of the examiner. Immediately after stimulation patients were asked to point to the g visual analog scale VAS scale (no pain = 0 and worst pain = 10 cm) to the nearest full centimeter number describing their pain perception. Brushing the child's teeth will identify if the child has hypersensitivity and the VAS is used in the same way.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 9 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • children whose parents or legal guardians accept and sign the informed consent form; -children who assent to participate into the research;

  • aged between 6 and 9 years;

  • exhibiting good general health conditions and cooperative behavior;

  • presenting at least one MIH molar.

Exclusion criteria:
  • children presenting health conditions that impair the dental treatment, or children undergoing orthodontic treatment;

  • MIH molars that present opacities not located on the occlusal surface, with post-eruptive breakdown, with the occlusal surface totally or partial covered by a gingival operculum, with caries dentine lesion (ICCMS score C), restorations or sealants.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Isaac Murisi Pedroza Guadalajara Jalisco Mexico 47620

Sponsors and Collaborators

  • Isabel Cristina Olegário da Costa
  • University of Guadalajara
  • University of Dublin, Trinity College
  • Academic Centre for Dentistry in Amsterdam

Investigators

  • Study Chair: Daniela Hesse, Professor, Academic Centre for Dentistry in Amsterdam
  • Principal Investigator: Isaac M Pedroza Uribe, MSc, University of Guadalajara

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Isabel Cristina Olegário da Costa, PhD, University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT03870958
Other Study ID Numbers:
  • MIHMex
First Posted:
Mar 12, 2019
Last Update Posted:
Sep 16, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2020